AGP Executive Report
Last update: 11 hours agoSyphilis surge in Latin America: Chile’s Health Ministry reports syphilis rates rising 2.4x from 2016 to 2025 (55.2 cases per 100,000), with cases concentrated among men 15–39, as PAHO warns the Americas hold over 40% of global syphilis cases and are also seeing increases in HIV and gonorrhea. Food safety alert: A U.S. recall and lawsuit linked to Publix frozen GreenWise organic blueberries highlight E. coli illness risk; the supplier is reported as Chile-based, keeping cross-border food safety in focus. Cancer drug deal: AstraZeneca secured exclusive global rights to Dizal’s lung cancer drug Zegfrovy (sunvozertinib), with potential deal value up to $1.5B, expanding options for EGFR exon 20 insertion NSCLC. Income and health access context: INE says half of employed people in Chile earned $680,000/month or less in 2025, underscoring affordability pressures that can affect healthcare and prevention. Local health tragedy: Queenstown hospital officials plan an internal review after a 7-year-old died hours after being discharged from the ED. Public health policy debate: A Chilean far-right bill would require doctors to offer women the option to listen to a fetus/embryo heartbeat before abortion, drawing criticism from health experts as coercive and revictimizing.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
